London-listed defence contractors **Babcock International (LSE: BABC)** and **Avon Technologies (LSE: AVTN)** revealed divergent impacts of the wartime economy on City firms, exposing sectoral resilience amid geopolitical volatility. Babcock’s £200m buyback and 10% revenue growth mask a £140m cost overrun on Type 31 frigates, while Avon’s 32% order surge reflects elevated defence valuations—yet its shares fell 9% as investors priced in acquisition risks. The data underscores how wartime demand distorts traditional profit metrics, with nuclear and aviation units outperforming marine divisions, and Avon’s M&A strategy hinging on selective adjacency plays.
The Bottom Line
- Babcock’s nuclear division (14% YoY growth) offsets marine underperformance, but the £140m Type 31 charge drags headline profit down 20% YoY to £293m—highlighting execution risks in long-cycle defence contracts.
- Avon’s 32% order surge (H1 2026) validates “highest conflict zones since WWII” thesis, yet its £450m market cap and 9% share drop signal caution over elevated defence valuations and acquisition timing.
- Macro spillover: Supply chain bottlenecks in shipbuilding (e.g., Portsmouth yard delays) may inflate UK defence inflation by 0.3–0.5% YoY, while Avon’s US/NATO contracts insulate it from sterling weakness.
Babcock’s Buyback Math: A Nuclear-Led Recovery with Marine Headwinds
The £200m share buyback—announced alongside a 10% revenue uplift—is a classic wartime capital allocation play: return cash to shareholders while locking in gains from high-margin segments. Here’s the math:
| Segment | Revenue (£bn) | YoY Growth | EBITDA Margin | Key Client |
|---|---|---|---|---|
| Nuclear | 2.1 | +14.0% | 18.5% | UK MoD (SSBN fleet) |
| Aviation | 0.431 | +33.5% | 12.8% | US DoD (C-130 upgrades) |
| Marine | N/A (£140m charge) | — | — | Royal Navy (Type 31) |
The nuclear segment—backed by the UK’s £31bn SSBN renewal programme—delivers 39% of Babcock’s EBITDA. Yet the marine division’s £140m charge (5.3% of revenue) stems from “out-of-sequence build activity” on Type 31 frigates, a red flag for investors scrutinizing Royal Navy cost overruns. The frigates’ £250m/unit price tag—up 12% from 2023 estimates—suggests inflation in defence procurement may seep into UK CPI via public sector wage settlements.
“Babcock’s buyback is a vote of confidence in its nuclear backlog, but the marine segment’s volatility is a reminder that defence margins aren’t immune to execution risk. The Type 31 overrun is a microcosm of broader supply chain strains in UK shipbuilding—where subcontractor delays and labor shortages are pushing lead times out by 12–18 months.”
Avon’s Order Surge: Why the 32% Jump Doesn’t Translate to Shareholder Gains
Avon’s 32% order increase (H1 2026) aligns with its claim that “active conflict zones are at their highest since WWII.” But the order book’s 11% YoY growth masks a valuation disconnect: its £450m market cap implies a 20x P/E—elevated for a company with 14% gross margins. Here’s the catch:
- Revenue growth (6.8% YoY) lags order intake due to long sales cycles (e.g., US DoD contracts take 18–24 months to convert).
- Operating profit jumped 166% YoY, but this reflects a low base (H1 2025’s $6.2m vs. $16.5m in 2026)—not sustainable margin expansion.
- Acquisition strategy risks overpaying in a sector where defence M&A multiples hit 12–15x EBITDA.
“Avon’s order book is a lagging indicator. The real question is whether its pipeline can clear at current margins—or if it’s forced to absorb acquisition premiums that erode returns. The 9% share drop suggests investors are already pricing in a correction.”
Market-Bridging: How Defence Stocks Are Reshaping the FTSE 100
Babcock and Avon’s performances reflect two macro trends:
- Defence as a hedge against geopolitical risk: The sector’s FTSE Defence Index has outperformed the broader FTSE 100 by 18% YTD, with **BAE Systems (LSE: BAE)** and **Thales (EPA: HO)** leading on order backlogs. However, Babcock’s marine woes show that even blue-chip defence stocks aren’t immune to execution risk.
- Supply chain inflation spillover: The Type 31 overrun aligns with UK construction input price inflation (10.2% YoY), which may pressure other shipbuilders like **Cammell Laird (LSE: CML)**. Meanwhile, Avon’s US/NATO contracts insulate it from sterling weakness, but its Wiltshire base exposes it to UK labor shortages—where defence sector wages now exceed national averages by 22%.
- Valuation arbitrage: Avon’s 9% share drop highlights how defence multiples are now trading at a 30% premium to historical averages. Comparables like **Elbit Systems (TASE: ESLT)** (22x P/E) and **Lockheed Martin (NYSE: LMT)** (18x) suggest Avon’s 20x is stretched—unless it delivers on M&A.
The Acquisition Trail: Can Avon Compound Value Without Overpaying?
Avon’s M&A focus on “strategic fit” and “margin upside” is critical given its £450m market cap. Potential targets include:
- UK-based cyber-physical security firms (e.g., **QinetiQ (LSE: QQ)** spin-offs) to diversify from body armor.
- US drone countermeasures** (e.g., **Raytheon’s EW portfolio**) to tap into NATO’s €1.3bn electronic warfare modernisation.
- European CBRN (chemical/biological/radiological) defence** to offset Brexit-related supply chain risks.
Antitrust hurdles loom: A £100m+ acquisition would trigger UK CMA scrutiny, especially if targeting US DoD suppliers. Meanwhile, **BAE Systems**—Avon’s larger rival—has a $1.2bn cash war chest and may outbid on adjacency plays.
The Takeaway: Wartime Economics Demand Precision Allocation
Babcock’s buyback and Avon’s order surge prove defence stocks are thriving—but not all segments are created equal. The key takeaways for investors:
- Stick to high-margin backlogs: Babcock’s nuclear division and Avon’s US/NATO contracts are safe bets; marine and early-stage orders are higher-risk.
- Watch execution risks: The Type 31 overrun is a warning that defence margins aren’t recession-proof. Monitor Royal Navy contract updates.
- Defence M&A is a double-edged sword: Avon’s strategy could pay off if it finds undervalued adjacencies, but elevated multiples mean due diligence is critical.
For the broader market, the story isn’t just about defence stocks—it’s about how wartime economics distort supply chains, labor markets, and inflation. The UK’s defence sector is now a microcosm of these tensions, with implications for everything from BoE rate decisions to minor businesses reliant on subcontracted defence work.
Disclaimer: The information provided in this article is for educational and informational purposes only and does not constitute financial advice.
